Kamada VP discloses initial share and option stake

Kamada Ltd executive Orit Pinchuk, VP Regulatory Affairs, filed an initial Form 3 reporting her equity position in the company.

Rhea-AI Filing Summary

Kamada Ltd executive Orit Pinchuk, VP Regulatory Affairs, filed an initial Form 3 reporting her equity position in the company. She directly holds 12,133 Ordinary Shares.

She also holds several option grants to purchase Ordinary Shares, including one grant exercisable for 15,000 shares at $6.15 per share, expiring on August 28, 2028, and additional grants each covering 15,000 shares at $7.55 per share with an expiration date of October 22, 2035 and different future exercise dates. The options are exercisable using a net-exercise method, and the U.S. dollar exercise prices are convenience translations from NIS based on the Bank of Israel exchange rate as of March 13, 2026.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Pinchuk Orit

Role VP Regulatory Affairs

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 75,000 contracts (Direct); Ordinary Shares — 12,133 shares (Direct)

Footnotes (2)

1. F1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Kamada (KMDA) Form 3 filing by Orit Pinchuk report?

The Form 3 reports VP Regulatory Affairs Orit Pinchuk’s initial equity holdings in Kamada. It details her direct ownership of Ordinary Shares and multiple option grants, including exercise prices, expiration dates, and the net-exercise feature translated from NIS to U.S. dollars.

How many Kamada (KMDA) Ordinary Shares does Orit Pinchuk directly hold?

Orit Pinchuk directly holds 12,133 Kamada Ordinary Shares. This figure reflects her current share ownership position reported in the Form 3, separate from any options that may convert into additional shares in the future if exercised.

What stock options are disclosed for Orit Pinchuk in the Kamada (KMDA) Form 3?

The filing lists several options to purchase Kamada Ordinary Shares. One grant is for 15,000 shares at an exercise price of $6.15 expiring August 28, 2028, plus additional 15,000-share grants at $7.55 expiring October 22, 2035, with staged exercise dates.

What are the exercise prices and expirations of Orit Pinchuk’s Kamada (KMDA) options?

One option grant covers 15,000 Ordinary Shares at $6.15 per share, expiring August 28, 2028. Several other grants each cover 15,000 shares at $7.55 per share, all expiring October 22, 2035, but with different future exercise dates before expiration.

How are the Kamada (KMDA) option exercise prices translated in Orit Pinchuk’s Form 3?

All exercise prices shown in U.S. dollars are convenience translations from Israeli shekels. They use the representative exchange rate of the Bank of Israel as of March 13, 2026, as noted in the filing’s footnote on currency conversion.

Does Orit Pinchuk’s Kamada (KMDA) Form 3 show any share purchases or sales?

The Form 3 does not show any buy or sell transactions. It consists of holding entries only, with zero reported purchase or sale counts and a neutral net buy-sell direction, indicating this is an initial statement of beneficial ownership.

What does net-exercise mean for Orit Pinchuk’s Kamada (KMDA) stock options?

Her options are exercisable using a net-exercise method, according to the footnote. In a net-exercise, the option holder typically receives fewer shares instead of paying cash, with some shares effectively covering the exercise cost at settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 07:08 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pinchuk Orit

(Last) (First) (Middle)

99 AYALON ST.

(Street)

ROSH HAAYIN L3 4861101

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Regulatory Affairs

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	12,133	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase Ordinary Shares(1)	02/28/2026	08/28/2028	Ordinary Shares	15,000	$6.15(2)	D
Options to purchase Ordinary Shares(1)	10/22/2026	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2027	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2028	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2029	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Orit Pinchuk	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.